2-乙硫基-4-羟基-6-三氟甲基嘧啶 | 657-58-9

• 物质功能分类: 医药中间体 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 中文名称: 2-乙硫基-4-羟基-6-三氟甲基嘧啶
• 英文名称: 2-ethylmercapto-6-trifluoromethyl-3H-pyrimidin-4-one
• 英文别名: 2-Aethylmercapto-6-trifluormethyl-3H-pyrimidin-4-on；2-Ethylthio-4-hydroxy-6-trifluoromethylpyrimidine；2-ethylsulfanyl-4-(trifluoromethyl)-1H-pyrimidin-6-one
• CAS: 657-58-9
• 化学式: C₇H₇F₃N₂OS
• 分子量: 224.207
• InChiKey: SGRGYWVPMIRUTA-UHFFFAOYSA-N

物化性质

• 沸点：
  226℃
• 密度：
  1.48
• 闪点：
  90℃

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 海关编码：
  2933599090

反应信息

• 作为反应物：
  描述：

  2-乙硫基-4-羟基-6-三氟甲基嘧啶 在 盐酸 、 溶剂黄146 作用下， 生成 6-(三氟甲基)尿嘧啶
  参考文献：
  名称：

  Source regions and timescales for the delivery of water to the Earth

  摘要：

  Abstract—In the primordial solar system, the most plausible sources of the water accreted by the Earth were in the outer asteroid belt, in the giant planet regions, and in the Kuiper Belt. We investigate the implications on the origin of Earth's water of dynamical models of primordial evolution of solar system bodies and check them with respect to chemical constraints. We find that it is plausible that the Earth accreted water all along its formation, from the early phases when the solar nebula was still present to the late stages of gas‐free sweepup of scattered planetesimals. Asteroids and the comets from the Jupiter‐Saturn region were the first water deliverers, when the Earth was less than half its present mass. The bulk of the water presently on Earth was carried by a few planetary embryos, originally formed in the outer asteroid belt and accreted by the Earth at the final stage of its formation. Finally, a late veneer, accounting for at most 10% of the present water mass, occurred due to comets from the Uranus‐Neptune region and from the Kuiper Belt. The net result of accretion from these several reservoirs is that the water on Earth had essentially the D/H ratio typical of the water condensed in the outer asteroid belt. This is in agreement with the observation that the D/H ratio in the oceans is very close to the mean value of the D/H ratio of the water inclusions in carbonaceous chondrites.

  DOI：

  10.1111/j.1945-5100.2000.tb01518.x
• 作为产物：
  描述：

  三氟乙酰乙酸乙酯 、 alkaline earth salt of/the/ methylsulfuric acid 生成 2-乙硫基-4-羟基-6-三氟甲基嘧啶
  参考文献：
  名称：

  Source regions and timescales for the delivery of water to the Earth

  摘要：

  Abstract—In the primordial solar system, the most plausible sources of the water accreted by the Earth were in the outer asteroid belt, in the giant planet regions, and in the Kuiper Belt. We investigate the implications on the origin of Earth's water of dynamical models of primordial evolution of solar system bodies and check them with respect to chemical constraints. We find that it is plausible that the Earth accreted water all along its formation, from the early phases when the solar nebula was still present to the late stages of gas‐free sweepup of scattered planetesimals. Asteroids and the comets from the Jupiter‐Saturn region were the first water deliverers, when the Earth was less than half its present mass. The bulk of the water presently on Earth was carried by a few planetary embryos, originally formed in the outer asteroid belt and accreted by the Earth at the final stage of its formation. Finally, a late veneer, accounting for at most 10% of the present water mass, occurred due to comets from the Uranus‐Neptune region and from the Kuiper Belt. The net result of accretion from these several reservoirs is that the water on Earth had essentially the D/H ratio typical of the water condensed in the outer asteroid belt. This is in agreement with the observation that the D/H ratio in the oceans is very close to the mean value of the D/H ratio of the water inclusions in carbonaceous chondrites.

  DOI：

  10.1111/j.1945-5100.2000.tb01518.x

文献信息

• [EN] 4-(PYRAZOL-3-YLAMINO) PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER<br/>[FR] DERIVES DE 4-(PYRAZOL-3-YLAMINO) PYRIMIDINE QUI S'UTILISENT DANS LE TRAITEMENT DU CANCER
  申请人：ASTRAZENECA AB

  公开号：WO2005040159A1

  公开（公告）日：2005-05-06

  A compound of Formula (I); wherein the substituents are as defined in the text for use in modulating insulin-like growth factor 1 receptor activity in a warm blooded animal such as man.

  一种化合物，其化学式为（I）；其中取代基如文本中定义的那样，用于调节类胰岛素生长因子1受体在温血动物（如人类）中的活性。
• 4-(Pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
  申请人：Nowak Thorsten

  公开号：US20070037888A1

  公开（公告）日：2007-02-15

  A compound of Formula (I); wherein the substituents are as defined in the text for use in modulating insulin-like growth factor 1 receptor activity in a warm blooded animal such as man.

  化合物公式（I）中的取代基如文本中所定义，用于调节温血动物（如人）中胰岛素样生长因子1受体的活性。
• 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
  申请人：AstraZeneca AB

  公开号：EP1678169B1

  公开（公告）日：2009-07-22
• US7579349B2
  申请人：——

  公开号：US7579349B2

  公开（公告）日：2009-08-25